| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/1999 | EP0917461A1 Device for topical treatment of acne and its method of manufacture |
| 05/26/1999 | EP0917458A1 Lyophilized thioxanthenone antimumor agents |
| 05/26/1999 | EP0917457A1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 05/26/1999 | EP0917427A1 Teat dipping agent |
| 05/26/1999 | EP0869789A4 Antiviral agent |
| 05/26/1999 | EP0836506A4 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 05/26/1999 | EP0823907B1 PROCESS FOR PREPARING (-)-TRANS-N-p-FLUOROBENZOYLMETHYL-4-(p-FLUOROPHENYL)-3-[[3,4-(METHYLENEDIOXY)PHENOXY]METHYL]-PIPERIDINE |
| 05/26/1999 | EP0817769B1 Borneol esters, process for their preparation and their pharmaceutical use |
| 05/26/1999 | EP0804459A4 Therapeutic compound - fatty acid conjugates |
| 05/26/1999 | EP0777663B1 Use of substituted 6-amino-4h-pyrans |
| 05/26/1999 | EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/26/1999 | EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/26/1999 | EP0746545B1 Nipecotic acid derivatives as antithrombic compounds |
| 05/26/1999 | EP0707482B1 Erythromycin derivatives |
| 05/26/1999 | EP0686625B1 Anthranilic acid derivative |
| 05/26/1999 | EP0639195B1 2-acyloxycephem derivatives as elastase inhibitors |
| 05/26/1999 | EP0630181B1 Nutritional product for trauma and surgery patients |
| 05/26/1999 | EP0611372B1 Photosensitizers |
| 05/26/1999 | EP0580759B1 Methods and compositions for isolating taxanes |
| 05/26/1999 | EP0516795B1 Medicaments containing a quisqualate receptor antagonist and a dopamine agonist for the treatment of parkinson's disease |
| 05/26/1999 | CN1217752A Process for producing high-molecular-weight compounds of phenolic compounds etc. and use thereof |
| 05/26/1999 | CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system |
| 05/26/1999 | CN1217731A Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using same |
| 05/26/1999 | CN1217721A Method for treating or preventing interstitial cystitis |
| 05/26/1999 | CN1217720A Benzofuryl derivatives and their use |
| 05/26/1999 | CN1217719A Novel benzofuranone derivative and process for producing same |
| 05/26/1999 | CN1217716A Crystal modified body of medicine |
| 05/26/1999 | CN1217715A 2-thioxotetrahydropyrimidin-4-one derivative |
| 05/26/1999 | CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
| 05/26/1999 | CN1217713A Sulphur derivatives with retroamide bond as endothelin-converting enzyme inhibitors |
| 05/26/1999 | CN1217711A Aryl substituted cyclic amines as selective dopamine D3 ligands |
| 05/26/1999 | CN1217662A Water soluble paclitaxel prodrugs |
| 05/26/1999 | CN1217660A Method for retreatment of patients afflicted with Hepatitis C using consensus interferon |
| 05/26/1999 | CN1217658A Dicloroanilicnophenylacetic acid/gamma-cyclodextrin inclusion compounds |
| 05/26/1999 | CN1217657A Nasal administration of agents for treatment of delayed onset emesis |
| 05/26/1999 | CN1217656A Patch containing isosorbide dinitrate |
| 05/26/1999 | CN1217655A Modified release multiple-units dosage composition |
| 05/26/1999 | CN1217654A Process for production of powdered pulmoney surfactant preparations |
| 05/26/1999 | CN1217651A Sunscreen composition comprising solid elastomeric organopolysiloxzane |
| 05/26/1999 | CN1217335A Method for preparing precursor medicine |
| 05/26/1999 | CN1217334A Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 05/26/1999 | CN1217332A Metal protease inhibitor, preparation method therefor and medicinal composition containing same |
| 05/26/1999 | CN1217327A D-proline derivative |
| 05/26/1999 | CN1217187A Anti-parasite oral spray containing evericin and ivermectin for sheep |
| 05/26/1999 | CN1217186A Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components |
| 05/26/1999 | CN1217185A Anti-tumor noval use of cinnamamide |
| 05/26/1999 | CN1217184A Controlled-release preparation of Tekening (medicine) |
| 05/26/1999 | CN1043473C 8-substituted xanthines as selective adenosine receptor agents |
| 05/26/1999 | CA2254434A1 Droloxifene pharmaceutical compositions |
| 05/25/1999 | US5907061 Amidation a nitrobenzoylhalide with a saturated alkylamine to form a drug treating parkinson's disease or slow the progressive loss of function |
| 05/25/1999 | US5907047 Bactericides, fungicides |
| 05/25/1999 | US5907042 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
| 05/25/1999 | US5907038 Azepanes |
| 05/25/1999 | US5907030 Fatty acid derivatives of sulfhydryl containing peptides and proteins; for increased absorption of theraputic compounds across mucous membranes and skin |
| 05/25/1999 | US5906996 Tetramine treatment of neurological disorders |
| 05/25/1999 | US5906993 Anticancer, antitumor agent |
| 05/25/1999 | US5906990 Taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 05/25/1999 | US5906989 Cyclopentane(ENE) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 05/25/1999 | US5906988 Methods of treatment using ranolazine and related piperazine derivatives |
| 05/25/1999 | US5906987 Hormone replacement therapy |
| 05/25/1999 | US5906985 Treating neurodegenerative diseases, central nervous disorder and as antipsychotic, anticonvulsant, analgesic and antiemetic agents |
| 05/25/1999 | US5906984 Treatment of marrow failure states |
| 05/25/1999 | US5906979 Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility |
| 05/25/1999 | US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes |
| 05/25/1999 | US5906832 Time release agents for epileptic drugs into intestines |
| 05/25/1999 | US5906821 Viral nucleotide sequences |
| 05/25/1999 | US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance |
| 05/25/1999 | US5906816 Method for treatment of autoimmune diseases |
| 05/25/1999 | US5906812 Useful for treating intrisic and extrinsic aging such as wrinkles, fine lines, actinic blemishes, dyschromias, dermatitis or scars in human skin; cosmetics |
| 05/25/1999 | US5906811 Reducing free radical damage by tobacco or environmental pollutants administering a mixture of glutathione, ascorbic acid, selenium or selenium compound, a sulphur containing amino acid, as mouthwashes, mouth sprayer, nasal inhaler |
| 05/25/1999 | US5906808 Adding sodium benzoate to pure water and agitating, adding sodium sesquicarbonate, heating the mixture, controlling the temperatue and adding cetyl lactate an emulsifier, then adding cyclohexidine or salt, filling the aerosol container |
| 05/25/1999 | CA2154257C Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 05/25/1999 | CA2138977C Cosmetic containing phospholipids and fluorocarbon compounds |
| 05/25/1999 | CA2126611C Opiod formulations having extended controlled release |
| 05/25/1999 | CA2120062C Use of sulodexide and of medicines containing it in the treatment of diabetic nephropathy |
| 05/25/1999 | CA2090574C Method of inhibiting nitric oxide formation |
| 05/25/1999 | CA2070497C Novel platinum (ii) complex and antitumor agent |
| 05/25/1999 | CA2062299C Cyclopropane derivatives |
| 05/25/1999 | CA2038011C Processes for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds |
| 05/25/1999 | CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one |
| 05/25/1999 | CA1340561C Process for preparing ciprofloxacine |
| 05/25/1999 | CA1340554C Derivatives of pyrido-benzothiazine with high anti-microbial activity |
| 05/20/1999 | WO1999024613A1 Human blood bacterium |
| 05/20/1999 | WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 05/20/1999 | WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 05/20/1999 | WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 05/20/1999 | WO1999024565A1 Methods and compositions for immunomodulation |
| 05/20/1999 | WO1999024559A2 Nuclear targeting by means of streptococcal protein h |
| 05/20/1999 | WO1999024490A1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 05/20/1999 | WO1999024475A1 Piperazine-cyclodextrin complexes |
| 05/20/1999 | WO1999024474A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers |
| 05/20/1999 | WO1999024471A1 Opiate, cannabinoid, and estrogen receptors |
| 05/20/1999 | WO1999024460A2 Dipeptide nitriles |
| 05/20/1999 | WO1999024451A2 Adenosine a1 receptor agonists |
| 05/20/1999 | WO1999024450A2 Adensine a1 receptor agonists |
| 05/20/1999 | WO1999024449A2 Adenosine a1 receptor agonists |
| 05/20/1999 | WO1999024448A2 New sophoroselipids, method for their production and use |
| 05/20/1999 | WO1999024447A1 Drugs, foods or drinks with the use of algae-derived physiologically active substances |
| 05/20/1999 | WO1999024440A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 05/20/1999 | WO1999024436A1 1'-[4-[1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro [isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides |